New weapon against superbugs: Real-World test begins
Disease control
ENROLLING_BY_INVITATION
This study aims to see how well a new antibiotic combination (aztreonam-avibactam) works in real hospital settings for patients with serious infections caused by bacteria that resist most other drugs. It will track about 100 patients in intensive care or infectious disease units,…
Sponsor: French Society for Intensive Care • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC